BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kuros Biosurgery AG 

Technoparkstrasse 1

Zurich    CH-8005  Switzerland
Phone: 41-0-44-445-36-00 Fax: 41-0-44-445-36-01


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Kuros Biosurgery AG Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 9/1/2011 7:18:56 AM
Kuros Biosurgery AG Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate 8/17/2011 5:55:23 AM
Kuros Biosurgery AG Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing 7/19/2011 6:23:26 AM
Kuros Biosurgery AG Announces Allowance of European Patent for Synthetic Biomaterials 6/20/2011 6:45:31 AM
Kuros Biosurgery AG Completes Patient Recruitment In A Phase Iib Trial Of Kur-111 In Patients With Tibial Plateau Fractures 6/8/2009 2:05:45 PM
Kuros Biosurgery AG Announces Grant Of United States Patent For Synthetic Biomaterials 10/13/2008 2:17:03 PM
Kuros Biosurgery AG and Aeris Therapeutics, Inc. Announce Exclusive License Agreement in the Field of Lung Volume Reduction 9/23/2008 6:48:19 AM
Kuros Biosurgery AG Announces Results Of ONE-Month Follow-Up Of Phase IIa Trial of KUR-212 in Patients with Burns requiring Mesh Grafting; KUR-212 Meets Phase IIa Trial Primary Endpoint 8/11/2008 11:51:36 AM
Kuros Biosurgery AG Appoints Beat Neukom as its Chief Financial Officer 7/7/2008 12:36:10 PM
Kuros Biosurgery AG Starts Phase IIb Clinical Trial With Kur-113 In Open Tibial Fractures 6/10/2008 9:28:39 AM
12